(VIANEWS) – Stantec (STN), The Ensign Group (ENSG), Coca Cola Femsa S.A.B. de C.V. (KOF) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Stantec (STN)
14.7% sales growth and 14.18% return on equity
Stantec Inc. provides e professional services in the areas of infrastructure and facilities to the public and private sectors clients in Canada, the United States, and internationally. The company provides consulting services in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics. It also offers planning and design consulting services to clients in residential, logistics, retail, infrastructure, energy, higher education, and urban regeneration sectors; architectural and interior design, and planning services in the science and technology, commercial workplace, higher education, residential, and hospitality markets. In addition, it provides transportation planning and engineering services; project delivery consultancy services for mining, resources, and industrial infrastructure projects; and paleontological and archaeological services for the rail, transportation, water, and power and energy sectors. Further, the company offers environmental and cultural resource compliance services, as well as serves science and technology, commercial workplace, higher education, residential, and hospitality markets. Additionally, it is involved in the design, development, and delivery of sustainable projects; and design, construction administration, commissioning, maintenance, decommissioning, and remediation activities. The company was formerly known as Stanley Technology Group Inc. and changed its name to Stantec Inc. in October 1998. Stantec Inc. was founded in 1954 and is headquartered in Edmonton, Canada.
Earnings Per Share
As for profitability, Stantec has a trailing twelve months EPS of $2.24.
PE Ratio
Stantec has a trailing twelve months price to earnings ratio of 35.19. Meaning, the purchaser of the share is investing $35.19 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.18%.
Volume
Today’s last reported volume for Stantec is 67979 which is 41.71% below its average volume of 116630.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Stantec’s EBITDA is 1.6.
2. The Ensign Group (ENSG)
11.3% sales growth and 18.78% return on equity
The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company operates in two segments, Skilled Services and Real Estate. The company offers skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; and physical, occupational, and speech therapies and other rehabilitative and healthcare services. It also provides standard services, such as room and board, special nutritional programs, social, recreational, entertainment, and other services. In addition, the company offers senior living, as well as mobile diagnostics services; leases real estate properties; and provides other ancillary services consisting of digital x-ray, ultrasound, electrocardiogram, laboratory, sub-acute, and patient transportation services to people in their homes or at long-term care facilities. As of April 4, 2022, it operated 252 healthcare facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
Earnings Per Share
As for profitability, The Ensign Group has a trailing twelve months EPS of $4.34.
PE Ratio
The Ensign Group has a trailing twelve months price to earnings ratio of 26.11. Meaning, the purchaser of the share is investing $26.11 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.78%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 22.2%, now sitting on 3.56B for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
The Ensign Group’s EBITDA is 2.19.
3. Coca Cola Femsa S.A.B. de C.V. (KOF)
11.2% sales growth and 17.07% return on equity
Coca-Cola FEMSA, S.A.B. de C.V., a franchise bottler, produces, markets, sells, and distributes Coca-Cola trademark beverages. The company offers sparkling beverages, including colas and flavored sparkling beverages; and waters and still beverages, such as juice drinks, coffee, teas, milk, value-added dairy products, sports drinks, energy drinks, and plant-based drinks. It provides a portfolio of products through retail outlets, such as wholesale supermarkets, discount stores, and convenience stores; retailers, such as restaurants and bars, as well as stadiums, auditoriums, and theaters; points-of-sale outlets; and home delivery and other locations. The company also distributes and sells Heineken beer products in its Brazilian territories. It operates in Mexico, Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Brazil, Argentina, and Uruguay. Coca-Cola FEMSA, S.A.B. de C.V. was founded in 1979 and is based in Mexico City, Mexico. Coca-Cola FEMSA, S.A.B. de C.V. is a subsidiary of Fomento Economico Mexicano, S.A.B. de C.V.
Earnings Per Share
As for profitability, Coca Cola Femsa S.A.B. de C.V. has a trailing twelve months EPS of $5.94.
PE Ratio
Coca Cola Femsa S.A.B. de C.V. has a trailing twelve months price to earnings ratio of 16.21. Meaning, the purchaser of the share is investing $16.21 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.07%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Coca Cola Femsa S.A.B. de C.V. ‘s EBITDA is 0.09.
4. Verisk Analytics (VRSK)
10.4% sales growth and 66.78% return on equity
Verisk Analytics, Inc. provides data analytics solutions to the insurance markets in the United States and internationally. The company provides predictive analytics and decision support solutions to customers in rating, underwriting, claims, catastrophe and weather risk, global risk analytics, and various other fields. It focuses on the prediction of loss, selection and pricing of risk, and compliance with their reporting requirements for property and casualty insurance customers, as well as develops machine learned and artificially intelligent models to forecast scenarios and produce standard and customized analytics that help its customers to manage their businesses, including detecting fraud before and after a loss event, and quantifying losses. The company was founded in 1971 and is headquartered in Jersey City, New Jersey.
Earnings Per Share
As for profitability, Verisk Analytics has a trailing twelve months EPS of $5.34.
PE Ratio
Verisk Analytics has a trailing twelve months price to earnings ratio of 44.23. Meaning, the purchaser of the share is investing $44.23 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 66.78%.
5. Option Care Health (OPCH)
7.9% sales growth and 18.54% return on equity
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and others; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Earnings Per Share
As for profitability, Option Care Health has a trailing twelve months EPS of $1.42.
PE Ratio
Option Care Health has a trailing twelve months price to earnings ratio of 22.51. Meaning, the purchaser of the share is investing $22.51 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.54%.
Moving Average
Option Care Health’s worth is above its 50-day moving average of $30.10 and above its 200-day moving average of $31.46.
Yearly Top and Bottom Value
Option Care Health’s stock is valued at $31.97 at 09:22 EST, way under its 52-week high of $35.74 and way higher than its 52-week low of $24.23.
Sales Growth
Option Care Health’s sales growth is 6.2% for the ongoing quarter and 7.9% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.1%, now sitting on 4.21B for the twelve trailing months.
6. MYR Group (MYRG)
7.1% sales growth and 15.76% return on equity
MYR Group Inc., through its subsidiaries, provides electrical construction services in the United States and Canada. It operates through two segments, Transmission and Distribution, and Commercial and Industrial. The company's Transmission and Distribution segment offers a range of services on electric transmission and distribution networks, and substation facilities, including design, engineering, procurement, construction, upgrade, maintenance, and repair services with primary focus on construction, maintenance, and repair to customers in the electric utility industry. Its services include construction and maintenance of high voltage transmission lines, substations, and lower voltage underground and overhead distribution systems, and renewable power facilities; and limited gas construction services, as well as emergency restoration services in response to hurricane, ice, or other storm related damages. This segment serves as a prime contractor to customers, such as investor-owned utilities, cooperatives, private developers, government-funded utilities, independent power producers, independent transmission companies, industrial facility owners, and other contractors. Its Commercial and Industrial segment provides services, such as design, installation, maintenance, and repair of commercial and industrial wiring; and installation of traffic networks, bridge, roadway, and tunnel lighting. This segment offers its services for airports, hospitals, data centers, hotels, stadiums, convention centers, renewable energy projects, manufacturing plants, processing facilities, waste-water treatment facilities, mining facilities, and transportation control and management systems. It serves general contractors, commercial and industrial facility owners, governmental agencies, and developers. MYR Group Inc. was founded in 1891 and is headquartered in Henderson, Colorado.
Earnings Per Share
As for profitability, MYR Group has a trailing twelve months EPS of $5.44.
PE Ratio
MYR Group has a trailing twelve months price to earnings ratio of 24.61. Meaning, the purchaser of the share is investing $24.61 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.76%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 2.1% and a drop 4.3% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 17.5%, now sitting on 3.5B for the twelve trailing months.
